Novartis calls on Covance to help with Big Data

By Gareth Macdonald

- Last updated on GMT

Related tags Pharmaceutical industry

Novartis teams with Covance on big data
Novartis teams with Covance on big data
Covance’s collection of drug development data is set to get bigger though a collaboration with Swiss drugmaker Novartis.

The agreement – financial terms of which were not disclosed – with see Covance work with scientist at Novartis’ research arm – the Novartis Institutes for Biomedical Research (NIBR) to develop a data warehouse for preclinical and clinical data.

The project will focus on expanding NIBR’s existing data storage architecture, which already houses results from the Swiss drugmakers research projects, into a platform capable of accommodating more results and allowing researchers to access them more easily.

For Covance the main driver for using NIBR’s existing system as a basis is “that it can effectively store both preclinical and clinical data in a single repository​,” according to Covance’s chief data officer Dimitris Agrafiotis.

He explained that: “Integrating data across the preclinical and clinical divide is critical for advancing a molecule along the development pipeline and for enabling translational research​.”

Specifics of the agreement have not been disclosed, although according to Covance any technology developed will be an important component of its “clinical data integration services​” and underpin its “risk-based, centralized and medical monitoring solutions​.”

The deal comes weeks after the preclinical trial focused contract research organisation (CRO) teamed up with Fresenius unit Frenova Renal Research​ on a data focused project.

Like the Novartis agreement, the Frenova deal granted Covance access to a large collection of data, however, the focus was on using the CROs analytical capabilities to design better protocols for studies of chronic kidney disease.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more